TAMARIS. International Multicentre Trial of genetically modified growth factor in critical limb ischemia.

Search results

• 2011

  Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia

  Belch, J. (Lead / Corresponding author), Hiatt, W. R., Baumgartner, I., Driver, I. V., Nikol, S., Norgren, L., Van Belle, E. & TAMARIS Comm Investigators, 4 Jun 2011, In: Lancet. 377, 9781, p. 1929-1937 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Fibroblast Growth Factor 1 (FGF1) 100%
  • Gene Therapy 100%
  • Randomized Placebo-controlled Trial 100%
  • Amputation 100%
  • Critical Limb Ischemia 100%

  312   Link opens in a new tab Citations (Scopus)